Top Markets
#1 Akedo Akedo +61.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.50%
#4 Cross Cross +46.58%
#5 Black Phoenix Black Phoenix +34.22%
#6 Velvet Velvet +31.90%
#7 OVERTAKE OVERTAKE +27.47%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.31%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.54%
#10 Movement Movement +13.62%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
OncoCyte Corporation OncoCyte Corporation

OncoCyte Corporation

OCX
Rangering i aksjer #38925
OncoCyte Corporation is a molecular diagnostics firm that conceptualizes,... OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.
Aksjekurs
$2.84
Sist synkronisert: 2025-07-14
Markedsverdi
$729.71K
Endring (1 dag)
-0.70%
Endring (1 år)
0.00%
Land
US
Handel OncoCyte Corporation (OCX)

Kategori

Healthcare
Aksjeprishistorikk for OncoCyte Corporation (OCX)
Høyeste sluttskurs: $2.94 den 2025-07-01

Laveste sluttskurs: $143.30 den 2015-12-01
Aksjeprishistorikk for OncoCyte Corporation fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 27.15%
2024 -24.10%
2023 -60.24%
2022 -83.06%
2021 -0.14%
2020 13.17%
2019 31.74%
2018 -71.95%
2017 -19.84%
2016 -5.81%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.69 30.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $848.55 30.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE